Integrated fetal testing in growth restriction: combining multivessel Doppler and biophysical parameters
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The criteria for a successful screening test are well defined. The targeted condition must be an important health problem—at least 80% of the population should be at risk. The epidemiology, natural history and disease spectrum must be well delineated. There must be an identifiable early stage with a sufficiently long latent phase to allow intervention, which will change outcome. The employed tests should be simple, precise and applicable to the target population. The tests should be well validated with a known distribution of results and a suitable cut-off level to identify pre-disease. If a screening policy is to be finalized, there should be evidence from high-quality randomized controlled trials that the screening program is clinically, financially, socially and ethically acceptable and is effective in reducing morbidity or mortality. And there should be a plan for managing and monitoring the screening program and an agreed set of quality assurance standards. These criteria have yet to be fulfilled for any test of fetal well-being. Cardiotocography (CTG), Doppler and biophysical profile score (BPS) are the principal antenatal testing modalities. These have predominantly been compared in their ability to predict fetal compromise and optimize the timing of intervention1, 2. However, the prognostic and diagnostic information gained in each testing modality is in great part independent of each other. The question that I will address here is: might it be better to combine, or integrate these modalities3? We have no accurate estimate of the impact of IUGR since the effects of this condition extend from fetal life all the way into adulthood4. The interactions between maternal, placental and fetal factors in the regulation of growth and development are complex. While the impact of these factors on long- and short-term outcome is still under investigation, considerable insight into natural disease history in fetal life has been gathered. Abnormal villous development and/or trophoblast invasion compromises fetal nutrient and waste exchange and causes disturbed placental blood flow dynamics. This condition may manifest as overt abnormalities of blood flow in fetoplacental and uterine vessels, fetal growth restriction, abnormal fetal behavior, abnormal fetal heart rate patterns, a decline in amniotic fluid production, or a variable combination of the above. Once a discrepancy between placental supply and fetal demand is established, there are several possibilities. If placental disease precludes fetal growth and development, stillbirth occurs. If placental disease is less severe and survival is made possible through a series of adaptations, the price may be long-term dysfunction. If placental disease is very mild, growth and development may still be perceived to be normal but fall short of the genetically determined potential. Decompensation may occur at any time, triggered by aggravation of the maternal, placental or fetal condition, or by the stress of labor. Irrespective of intervention the fetus remains at risk for additional damage and stillbirth. A variety of cardiovascular and central nervous system (CNS) responses to placental insufficiency have been described. Evidence of abnormal placentation may be found in the uterine circulation as elevation of the Doppler resistance index or persistence of an early diastolic notch5. In the umbilical circulation, end-diastolic velocity may be normal, decreased, absent or reversed (A/REDV) proportional to the degree of villous vascular damage6. Elevated placental blood flow resistance favors redistribution of cardiac output towards vital organs7. This may be apparent through increased aortic blood flow impedance8, a decrease in the ratio of cerebral to placental Doppler indices (cerebroplacental ratio = CPR)9 or a decline in amniotic fluid volume10 as a sign of decreased renal perfusion. With fetal perception of hypoxemia additional vascular responses such as 'brain sparing' may be invoked to enhance local perfusion11, 12. Although often used interchangeably, redistribution (umbilical artery A/REDV), centralization (low CPR) and brain sparing appear to be different vascular responses. While the CPR is almost always abnormal in fetuses with overtly abnormal umbilical artery flow, brain sparing may develop independently of the umbilical artery waveform13-15. A number of changes in fetal biophysical variables are observed with chronic placental dysfunction. These may reflect abnormal maturation of brainstem reflexes, chronic hypoxemia, redistribution of cardiac output or a combination of these. Autonomic reflexes superimposed on the intrinsic cardiac activity determine fetal heart rate. These reflexes originate from the brainstem and may be modulated through incorporation of signals from higher centers, the reticular activating system and peripheral sensory inputs. Variations of the heart rate and episodic accelerations coupled to fetal movement are indicative of normal fun
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baschat, A. A., Gembruch, U., & Harman, C. R. (2001) · Ultrasound in Obstetrics & Gynecology · doi:10.1046/j.0960-7692.2001.00591.x · Cited by 435
Self-citationThe GRIT Study Group, & article, P. A. L. A. T. E. O. T. (2003) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1046/j.1471-0528.2003.02014.x · Cited by 305
Severi, F. M., Bocchi, C., Visentin, A., Falco, P., Cobellis, L., Florio, P., Zagonari, S., & Pilu, G. (2002) · Ultrasound in Obstetrics & Gynecology · doi:10.1046/j.1469-0705.2002.00652.x · Cited by 248
Baschat, A. A., & Weiner, C. P. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(00)70505-9 · Cited by 151
Self-citation
Cited by
Melamed, N., Baschat, A., Yinon, Y., Athanasiadis, A., Mecacci, F., Figueras, F., Berghella, V., Nazareth, A., Tahlak, M., McIntyre, H. D., et al. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13522 · Cited by 570
Self-citationPredictors of neonatal outcome in early-onset placental dysfunction
Baschat, A. A., Cosmi, E., Bilardo, C. M., Wolf, H., Berg, C., Rigano, S., Germer, U., Moyano, D., Turan, S., Hartung, J., et al. (2007) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000253215.79121.75 · Cited by 485
Self-citationFetal responses to placental insufficiency: an update
Baschat, D. A. A. (2004) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2004.00273.x · Cited by 305
Defining normal and abnormal fetal growth: promises and challenges
Zhang, J., Merialdi, M., Platt, L. D., & Kramer, M. S. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.10.889 · Cited by 264
Fetal growth restriction due to placental disease
Baschat, A. A., & Hecher, K. (2004) · Seminars in Perinatology · doi:10.1053/j.semperi.2003.10.014 · Cited by 258
Self-citationSavchev, S., Figueras, F., Sanz-Cortes, M., Cruz-Lemini, M., Triunfo, S., Botet, F., & Gratacos, E. (2014) · Fetal Diagnosis and Therapy · doi:10.1159/000355525 · Cited by 182
Baschat, A. A., Gembruch, U., Weiner, C. P., & Harman, C. R. (2003) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.149 · Cited by 166
Self-citationThe role of the fetal biophysical profile in the management of fetal growth restriction
Baschat, A. A., Galan, H. L., Lee, W., DeVore, G. R., Mari, G., Hobbins, J., Vintzileos, A., Platt, L. D., & Manning, F. A. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.01.020 · Cited by 42
Self-citation
Metadata
- Authors
- Baschat, A. A.
- Venue
- Ultrasound in Obstetrics & Gynecology
- Publisher
- Wiley
- Published
- 2003-01
- Volume
- 21
- Issue
- 1
- Pages
- 1-8
- ISSN
- 0960-7692 (ISSN-L)
- 1469-0705
- OpenAlex
- W2040905829
- Cited by
- 104
- References
- 4
- FWCI
- 11.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.